Polymorphisms in folate‐metabolizing enzymes and response to 5‐fluorouracil among patients with stage II or III rectal cancer (INT‐0144; SWOG 9304)

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|21|3329-3337

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.21, 2014-11, pp. : 3329-3337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adjuvant Radio-Chemotherapy in Stage II–III Rectal Cancer with 24-Hour Infusion of High-Dose 5-Fluorouracil and Folinic Acid: Evaluation of Feasibility

By  

Oncology Research and Treatment, Vol. 24, Iss. 5, 2001-10 ,pp. : 476-480

Karger

Access to resources Recommend Favorite

Delivery of neoadjuvant chemoradiation for patients with stage II and III rectal cancer is suboptimal

By  

CA: A CANCER JOURNAL FOR CLINICIANS, Vol. 66, Iss. 5, 2016-09 ,pp. : 357-358

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adjuvant Radio-Chemotherapy with 5-Fluorouracil and Leucovorin in Stage II and III Rectal Cancer: 12 Months vs. 6 Months of Therapy. A Study of the Association for Medical Oncology of the German Cancer Society

By  

Oncology Research and Treatment, Vol. 23, Iss. 4, 2000-09 ,pp. : 334-339

Karger

Access to resources Recommend Favorite

Microsatellite Instability Did Not Predict Individual Survival in Sporadic Stage II and III Rectal Cancer Patients

By  

Oncology, Vol. 72, Iss. 1-2, 2007-11 ,pp. : 82-88

Karger

Access to resources Recommend Favorite

Phase I/II Study of Paclitaxel and 5-Fluorouracil as Second-Line Therapy in Patients with Metastatic Breast Cancer

By  

Oncology Research and Treatment, Vol. 21, Iss. 4, 1998-09 ,pp. : 305-308

Karger

Access to resources Recommend Favorite